EuropaBio, The European Association for Bioindustries, EuropaBio, Avenue de l'Armée 6, 1040 Brussels, Belgium.
N Biotechnol. 2018 Jan 25;40(Pt A):140-143. doi: 10.1016/j.nbt.2017.05.010. Epub 2017 Jun 3.
Five years following the publication of the EU Bioeconomy Strategy, this article discusses the state of play of the bioeconomy in Europe. Placing specific focus on Industrial Biotech, it outlines ten pragmatic recommendations from BIO-TIC [BIO-TIC, A roadmap to a thriving industrial biotechnology sector in Europe, 2015], an EU FP7 funded project completed in 2015 and coordinated by EuropaBio, comprehensively examining the hurdles to the development of a bioeconomy in Europe, enabled by industrial biotech. These include improving opportunities for feedstock producers within the bioeconomy; investigating the scope for using novel biomass; developing a workforce which can maintain Europe's competitiveness in industrial biotechnology; introducing a long-term, stable and transparent policy and incentive framework to promote the bioeconomy; improving public perception and awareness of industrial biotechnology and bio-based products; identifying, leveraging and building upon EU capabilities for pilot and demonstration facilities; promoting the use of co-products from processing; improving the bioconversion and downstream processing steps; improving access to financing for large-scale biorefinery projects; developing stronger relationships between conventional and non-conventional players.
欧盟《生物经济战略》发布五年后，本文探讨了欧洲生物经济的现状。本文特别关注工业生物技术，概述了由 EuropaBio 协调的欧盟第七研发框架计划（FP7）资助项目 BIO-TIC[BIO-TIC，2015 年]提出的十大务实建议，该项目全面研究了阻碍欧洲生物经济发展的因素，而工业生物技术为生物经济的发展提供了可能性。这些因素包括：增加生物经济中原料生产商的机会；研究利用新型生物质的范围；培养能够保持欧洲在工业生物技术领域竞争力的劳动力；引入长期、稳定和透明的政策和激励框架，以促进生物经济；提高公众对工业生物技术和生物基产品的认识和意识；确定、利用和建立欧盟用于试点和示范设施的能力；促进加工副产品的使用；改进生物转化和下游加工步骤；改善大规模生物炼制项目的融资渠道；发展传统和非传统参与者之间更强的关系。
